Cargando…

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion

BACKGROUND: MiR-221/-222 are frequently overexpressed in breast cancer and are associated with increased malignancy. The specific modification of microRNAs (miRNAs) expression could be a promising strategy in breast cancer therapy, leading to the suppression of tumourigenic processes in tumour cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falkenberg, N, Anastasov, N, Rappl, K, Braselmann, H, Auer, G, Walch, A, Huber, M, Höfig, I, Schmitt, M, Höfler, H, Atkinson, M J, Aubele, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833215/ https://www.ncbi.nlm.nih.gov/pubmed/24129242 http://dx.doi.org/10.1038/bjc.2013.625

Ejemplares similares

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas
por: Aubele, M, et al.
Publicado: (2007)

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
por: Aubele, M, et al.
Publicado: (2008)

Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells
por: Anastasov, Nataša, et al.
Publicado: (2012)

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours
por: Gits, C M M, et al.
Publicado: (2013)

Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
por: Kawaguchi, T, et al.
Publicado: (2013)

Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221
por: Falkenberg, Natalie, et al.
Publicado: (2015)

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
por: Goto, Yusuke, et al.
Publicado: (2015)

RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH
por: Unger, K, et al.
Publicado: (2006)

miR-221 and miR-222 Simultaneously Target RECK and Regulate Growth and Invasion of Gastric Cancer Cells
por: Liu, Wenneng, et al.
Publicado: (2015)

microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma
por: Yau, T O, et al.
Publicado: (2014)

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
por: Yoshino, H, et al.
Publicado: (2011)

Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer
por: Huber, Michaela C., et al.
Publicado: (2016)

Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma
por: Halec, G, et al.
Publicado: (2013)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer
por: Ludyga, Natalie, et al.
Publicado: (2013)

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
por: Chiyomaru, T, et al.
Publicado: (2010)

Three‐dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer
por: Falkenberg, Natalie, et al.
Publicado: (2016)

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma
por: Takeshita, N, et al.
Publicado: (2013)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer
por: Sasahira, T, et al.
Publicado: (2012)

Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling
por: Chistiakov, Dmitry A., et al.
Publicado: (2015)

Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
por: Miyamoto, K, et al.
Publicado: (2016)

Multiparameter DNA content analysis identifies distinct groups in primary breast cancer
por: Dayal, J H S, et al.
Publicado: (2013)

In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues
por: Aubele, M, et al.
Publicado: (2010)

Chromosomal Imbalances are Associated with Metastasis-Free Survival in Breast Cancer Patients
por: Aubele, Michaela, et al.
Publicado: (2002)

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
por: White, N M A, et al.
Publicado: (2011)

miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC)
por: Kikkawa, N, et al.
Publicado: (2010)

Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2014)

Regulation of microRNA‐221, ‐222, ‐21 and ‐27 in articular cartilage subjected to abnormal compressive forces
por: Stadnik, Paulina S., et al.
Publicado: (2020)

miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions
por: Grignol, V, et al.
Publicado: (2011)

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
por: Gebauer, K, et al.
Publicado: (2013)

Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer
por: Morimura, R, et al.
Publicado: (2011)

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases
por: Akiyoshi, S, et al.
Publicado: (2012)

uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R
por: Huber, Michaela C., et al.
Publicado: (2016)

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer
por: Villadsen, S B, et al.
Publicado: (2012)

Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma
por: Hirajima, S, et al.
Publicado: (2013)

miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop
por: Zhang, Y, et al.
Publicado: (2015)

miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer
por: Zhang, J, et al.
Publicado: (2012)

Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study
por: Liao, S Y, et al.
Publicado: (2013)

Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells
por: Hirata, H, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ilrtgetgegpq3pn8svoqt9tddp